» Articles » PMID: 8544410

PDGF and TGF-beta Contribute to the Natural Course of Human IgA Glomerulonephritis

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 1995 Nov 1
PMID 8544410
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

PDGF and TGF-beta are known mediators of mesangial cell proliferation and matrix expansion. The presence of these regulatory factors was examined in 30 renal biopsies from patients with IgA glomerulonephritis (IgA-GN) at the mRNA and protein level. Normal renal tissue served as control. The mRNA expression of PDGF A/B chains, PDGF-beta R and TGF-beta 1 was evaluated by means of RT/PCR with subsequent Southern blot hybridization and/or non-radioactive in situ hybridization. In addition, PDGF-AB/BB, PDGF-beta R, TGF-beta isoforms (beta 1, beta 1 + 2, beta 2 + 3), the small TGF-beta 1 latency associated peptide (TGF-beta 1 LAP) and the extracellular matrix proteins tenascin and decorin were analyzed by immunocytochemistry. The expression of growth factors was correlated with light microscopic and clinical features. Compared to normal control kidneys, an increased expression of PDGF-BB/PDGF-beta R mRNAs and the corresponding proteins was observed in all biopsies with IgA-GN. Up-regulation was related to the degree of glomerular proliferation and the extent of fibrosing interstitial lesions. In contrast, there was a discordance between TGF-beta 1 mRNA and protein expression (evaluated by immunocytochemistry). In all biopsies, irrespective of the stage of the disease, abundant TGF-beta 1 transcripts were detected, whereas TGF-beta 1 immunoreactivity was expressed to a lesser degree and disclosed a more variable staining pattern. In patients with significant proliferative glomerular lesions and minor tubulointerstitial alterations, TGF-beta 1 positivity was confined to areas of glomerular proliferation, whereas in cases with more severe histology including sclerosing lesions TGF-beta 1 immunoreactivity was less prominent. The distribution and the intensity of TGF-beta 1 LAP staining commonly exceeded the positivity noted for TGF-beta 1, indicating only limited TGF-beta 1 activation. A decreased reactivity for tenascin accompanied the morphological features of glomerular sclerosis. The staining patterns and the fact that only very few inflammatory cells, particularly CD68 positive monocytes/macrophages, were detected in glomeruli confirm that predominantly resident glomerular cells (mesangial and endothelial cells) are the major source of up-regulated growth factor production in IgA-GN. Since the expression of PDGF-AB/BB paralleled the severity of proliferative glomerular changes, PDGF seems to represent a potential indicator of activity in this condition. It is suggested that an imbalance between PDGF and TGF-beta (by restricted translation and/or activation) production contribute to the progressive nature of IgA-GN.

Citing Articles

Role of TGFβ-producing regulatory T cells in scleroderma and end-stage organ failure.

Lu K, Tsai K, Hu W Heliyon. 2024; 10(15):e35590.

PMID: 39170360 PMC: 11336735. DOI: 10.1016/j.heliyon.2024.e35590.


Mesangioproliferative Kidney Diseases and Platelet-Derived Growth Factor-Mediated AXL Phosphorylation.

Bian Q, Anderson J, Zhang X, Huang Z, Ebefors K, Nystrom J Kidney Med. 2021; 3(6):1003-1013.e1.

PMID: 34939009 PMC: 8664734. DOI: 10.1016/j.xkme.2021.06.007.


Comparative efficacy of different renin angiotensin system blockade therapies in patients with IgA nephropathy: a Bayesian network meta-analysis of 17 RCTs.

Huo Z, Ye H, Ye P, Xiao G, Zhang Z, Kong Y PeerJ. 2021; 9:e11661.

PMID: 34268008 PMC: 8269645. DOI: 10.7717/peerj.11661.


Protective Effects and Metabolic Regulatory Mechanisms of Shenyan Fangshuai Recipe on Chronic Kidney Disease in Rats.

Deng X, Jiang N, Guo L, Wang C, Li J, Liu X Evid Based Complement Alternat Med. 2020; 2020:5603243.

PMID: 32908562 PMC: 7468650. DOI: 10.1155/2020/5603243.


Excessive activation of the TLR9/TGF-β1/PDGF-B pathway in the peripheral blood of patients with systemic lupus erythematosus.

Yuan Y, Yang M, Wang K, Sun J, Song L, Diao X Arthritis Res Ther. 2017; 19(1):70.

PMID: 28356164 PMC: 5372299. DOI: 10.1186/s13075-017-1238-8.